136 related articles for article (PubMed ID: 6380205)
1. Lacrimal and salivary secretion in Sjögren's syndrome: the effect of systemic treatment with bromhexine.
Prause JU; Frost-Larsen K; Høj L; Isager H; Manthorpe R
Acta Ophthalmol (Copenh); 1984 Jun; 62(3):489-97. PubMed ID: 6380205
[TBL] [Abstract][Full Text] [Related]
2. Bromhexine treatment of Sjögren's syndrome: effect on lacrimal and salivary secretion, and on proteins in tear fluid and saliva.
Manthorpe R; Frost-Larsen K; Høj L; Isager H; Prause JU
Scand J Rheumatol; 1981; 10(3):177-80. PubMed ID: 7027431
[TBL] [Abstract][Full Text] [Related]
3. Sjögren's syndrome, bromhexine, and tear secretion.
Mackie I; Seal DV
Br Med J; 1978 Aug; 2(6137):638. PubMed ID: 698633
[No Abstract] [Full Text] [Related]
4. Clinical trial of bromhexine in Sjögren's syndrome.
Avisar R; Savir H; Machtey I; Ovaknin L; Shaked P; Menache R; Allalouf D
Ann Ophthalmol; 1981 Aug; 13(8):971-3. PubMed ID: 7027873
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's syndrome treated with bromhexine: a reassessment.
Tapper-Jones LM; Aldred MJ; Cadogan SJ; Walker DM; Dolby AE; Hopkins R; Nuki G; Beck L
Br Med J; 1980 Jun; 280(6228):1356. PubMed ID: 7388541
[No Abstract] [Full Text] [Related]
6. Sialochemistry in evaluating bromhexine treatment of Sjögren's syndrome.
Nahir AM; Aryeh HB; Szargel R; Scharf Y; Gutman D; Blaustein Y; Scharf Y
Br Med J; 1979 Oct; 2(6194):833. PubMed ID: 509119
[No Abstract] [Full Text] [Related]
7. [The effect of bromhexin on the functional deficiency of the lacrimal apparatus and the salivary glands in Sjogren's syndrome].
Isager H; Frost-Larsen K; Manthorpe R; Westergaard L
Med Monatsschr; 1977 Dec; 31(12):582-3. PubMed ID: 593225
[No Abstract] [Full Text] [Related]
8. Sjörgren's syndrome treated with bromhexine: a randomised clinical study.
Frost-Larsen K; Isager H; Manthorpe R
Br Med J; 1978 Jun; 1(6127):1579-81. PubMed ID: 350346
[TBL] [Abstract][Full Text] [Related]
9. [Bromhexine in symptomatic treatment of Sjögren syndrome].
Fossaluzza V
Klin Monbl Augenheilkd; 1984 Oct; 185(4):292-5. PubMed ID: 6513403
[TBL] [Abstract][Full Text] [Related]
10. Effect of bromhexine on Sjögren's syndrome accompanied by rheumatoid arthritis.
Kawashima K
Nihon Ika Daigaku Zasshi; 1988 Apr; 55(2):191-200. PubMed ID: 3392169
[No Abstract] [Full Text] [Related]
11. Clinical trial of ambroxol (Mucosolvan) in Sjögren's syndrome.
Ichikawa Y; Tokunaga M; Shimizu H; Moriuchi J; Takaya M; Arimori S
Tokai J Exp Clin Med; 1988 Aug; 13(3):165-9. PubMed ID: 2978189
[TBL] [Abstract][Full Text] [Related]
12. Assessment of bromhexine as a treatment regimen in Sjögren's syndrome-like disease in the NOD (non-obese diabetic) mouse.
Nanni JM; Nguyen KH; Alford CE; Robinson CP; Stewart CM; Maeda N; Humphreys-Beher MG
Clin Exp Rheumatol; 1997; 15(5):515-21. PubMed ID: 9307859
[TBL] [Abstract][Full Text] [Related]
13. Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study.
Streckfus C; Bigler L; Navazesh M; Al-Hashimi I
Clin Oral Investig; 2001 Jun; 5(2):133-5. PubMed ID: 11480812
[TBL] [Abstract][Full Text] [Related]
14. Influence of bromhexine on tear lysozome level in keratoconjunctivitis sicca.
Scharf JM; Obedeanu N; Meshulam T; Nahir M; Merzbach D; Scharf JA; Zonis S
Am J Ophthalmol; 1981 Jul; 92(1):21-3. PubMed ID: 7258276
[No Abstract] [Full Text] [Related]
15. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Lipids in Saliva, Tears and Minor Salivary Glands of Sjögren's Syndrome Patients Using an HPLC/MS-Based Approach.
Fineide F; Chen X; Bjellaas T; Vitelli V; Utheim TP; Jensen JL; Galtung HK
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445702
[TBL] [Abstract][Full Text] [Related]
17. Sjögren's syndrome in systemic sclerosis. A clinical study of 26 patients.
Rasker JJ; Jayson MI; Jones DE; Matthews R; Burton JL; Rhys Davies E; Burton PA
Scand J Rheumatol; 1990; 19(1):57-65. PubMed ID: 2309104
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Sjogren's syndrome with bromhexine].
Kaarela K
Duodecim; 1978; 94(23):1510-2. PubMed ID: 729500
[No Abstract] [Full Text] [Related]
19. Mucosolvan in the treatment of patients with primary Sjögren's syndrome. Results from a double-blind cross-over investigation.
Manthorpe R; Petersen SH; Prause JU
Acta Ophthalmol (Copenh); 1984 Aug; 62(4):537-41. PubMed ID: 6385607
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the concentration and output of whole salivary constituents in patients with Sjögren's syndrome.
van der Reijden WA; van der Kwaak JS; Veerman EC; Nieuw Amerongen AV
Eur J Oral Sci; 1996 Aug; 104(4 ( Pt 1)):335-40. PubMed ID: 8930579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
